Nolato AB Class B

Nolato AB Class B

56.10
SEK
-1.30
(-2.26%)
2.65EPS
18.38P/E
13.11BMarket Cap
Oct 29Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
17.19
16.09
17.96
16.9
25.54
30.8
29.96
35.14
43.24
40
35.44
35.88
35.13
35.18
Basic EPS, GAAP
1.19
1.38
1.6
1.28
2.17
2.74
2.66
3.03
4.32
2.59
1.61
2.44
2.88
2.65
Free Cash Flow per Basic Share
1.37
0.48
1.09
0.92
1.88
2.25
3.03
2.97
1.66
-0.18
1.3
2.74
1.01
4.22
Dividend per Share
0.6
0.8
0.85
1
1.05
1.25
1.39
- -
1.59
1.9
1.9
1.5
1.5
- -
Book Value per Share
5.12
5.96
6.69
7.03
8.21
9.85
11.17
13.83
17.7
20.02
19.2
21.3
20.54
21.07
Tangible Book Value per Share
3.08
3.87
4.62
3.81
5.12
6.89
7.96
6.01
9.41
10.84
10.28
11.92
12.47
12.72
Basic Weighted Avg Shares
263
263
263
263
263
263
264
266
268
269
269
269
269
269
Sales/Revenue/Turnover
4,522
4,234
4,726
4,447
6,720
8,102
7,919
9,359
11,610
10,774
9,546
9,664
9,462
9,478
Operating Margin (%)
9
10.77
11.55
9.67
11.44
11.57
11.28
11.74
11.64
7.78
6.91
9.28
10.39
10.33
Depreciation Expense
157
165
181
193
231
248
376
408
472
544
596
604
567
- -
Net Income, GAAP
314
364
420
336
572
722
703
806
1,160
697
435
658
777
713
Effective Tax Rate (%)
22.08
21.21
24.32
23.29
21.75
21.61
17.97
20.51
17.2
20.34
29.38
22.41
20.96
23
Profit Margin (%)
6.94
8.6
8.89
7.56
8.51
8.91
8.88
8.61
9.99
6.47
4.56
6.81
8.21
7.52
Working Capital
262
294
445
639
909
1,091
1,503
958
1,768
1,895
1,952
1,920
1,568
1,510
LT Debt
- -
- -
- -
517
487
522
834
961
1,464
1,710
1,753
1,485
1,069
- -
Total Equity
1,348
1,567
1,759
1,850
2,159
2,592
2,966
3,699
4,768
5,392
5,171
5,738
5,532
5,675
Return on Invested Capital (%)
22.99
23.17
23.57
15.5
22.04
23.94
20.05
17.44
18.27
9.97
6.4
9.78
11.23
13.42
Return on Capital (%)
23.1
24.03
23.88
15.52
22.06
24.27
20.1
17.57
19.97
10.81
6.62
9.85
11.41
12.69
Return on Common Equity (%)
24.94
24.97
25.26
18.62
28.54
30.39
25.3
24.19
27.4
13.72
8.24
12.06
13.79
12.69

Capital Structure

SEK

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
385
- -
- -
LT Borrowings
897
- -
- -
LT Finance Leases
172
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
269
269
269
Market Capitalization
16,648
12,860
13,105

Working Capital

SEK

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
3,724
4,002
4,181
Cash, Cash Equivalents & STI
482
452
482
Accounts Receivable, Net
1,600
1,762
1,834
Inventories
1,086
1,109
1,208
Total Current Liabilities
2,156
2,383
2,671
Payables & Accruals
- -
- -
- -
ST Debt
385
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

SEK

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
12.63%
9.05%
-3.59%
Free Cash Flow
-78.18%
-184.79%
-62.96%
Net Income, GAAP
12.43%
7.15%
18.09%
Sales/Revenue/Turnover
8.63%
0.92%
-2.09%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

SEK

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
2,442
2,439
2,401
2,382
9,664
2025
2,453
2,395
- -
2,272
9,462
2026
2,357
2,454
- -
- -
- -

Quarterly Earnings Per Share

SEK

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.6
0.63
0.61
0.61
2.44
2025
0.74
0.79
- -
0.56
2.88
2026
0.67
0.63
- -
- -
- -

Quarterly Dividends Per Share

SEK

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
1.5
2025
- -
- -
- -
- -
1.5
2026
- -
- -
- -
- -
- -

Company Description

CEO
Anders Björklund
Full Time Employees
5,692
Sector
Electronic technology
Industry
Electronic production equipment
Address
NolatovAegen 32 Torekov SN Sweden 269 78
IPO Date
Jan 2, 1987
Website
nolato.com
Business
Nolato AB (publ) develops, manufactures, and sells customized products in polymer materials including plastics, silicones, and thermoplastic elastomers (TPE) for global customers in medical technology, pharmaceuticals, consumer electronics, telecommunications, automotive, hygiene, and selected industrial sectors; its offerings encompass the full value chain from concept development, product design, process optimization, high-volume production, post-processing, assembly, and logistics, with specialized capabilities in injection molding, micro molding, clean room production, dip molding, injection blow molding, silicone sponge extrusion, and tool manufacturing. The company operates through two primary business areas, Medical Solutions and Engineered Solutions, serving leading multinational clients with high-precision, sustainable solutions adhering to stringent quality and regulatory standards. Founded in 1938 and headquartered in Torekov, Sweden, Nolato maintains production and sales facilities across more than ten countries in Europe, Asia, and North America. Recent developments include a long-term cooperation agreement signed in late 2023 with a major existing customer for medical devices supporting drug administration in obesity and diabetes treatments, prompting a SEK 600 million investment starting in 2024 to expand manufacturing capacity by 7,000 square meters at its Mosonmagyaróvár facility in Hungary; ongoing expansions in Poland and Malaysia to support future growth; and emphasis on renewable energy procurement, achieving 89% of electricity from renewable sources globally in 2024.

Company News

  • Nolato AB (publ) (NLTBF) Q2 2026 Earnings Call Transcript

  • Nolato AB (publ) (NLTBF) Q1 2026 Earnings Call Transcript

  • Nolato AB (publ) (NLTBF) Q4 2025 Earnings Call Transcript

  • Nolato AB (publ) (OTCMKTS:NLTBF) Shares Up 8.8% – Here’s Why